Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.

Bagni K, Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Hansen CP, Preus Hasselby J, Holländer NH, Nissen M, Bjerregaard JK, Pfeiffer P, Yilmaz MK, Rasmussen LS, Nielsen SE, Johansen JS.

Eur J Cancer Care (Engl). 2020 Jan 6:e13219. doi: 10.1111/ecc.13219. [Epub ahead of print]

PMID:
31908093
2.

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.

Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Bojesen SE, Pfeiffer P, Bjerregaard JK, Nielsen SE, Andersen F, Holländer NH, Yilmaz MK, Rasmussen LS, Johansen JS.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):176-184. doi: 10.1158/1055-9965.EPI-19-0672. Epub 2019 Nov 4.

PMID:
31685562
3.

Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.

Chen IM, Willumsen N, Dehlendorff C, Johansen AZ, Jensen BV, Hansen CP, Hasselby JP, Bojesen SE, Pfeiffer P, Nielsen SE, Holländer NH, Yilmaz MK, Karsdal M, Johansen JS.

Int J Cancer. 2019 Oct 23. doi: 10.1002/ijc.32751. [Epub ahead of print]

PMID:
31642523
4.

Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review.

Tobberup R, Thoresen L, Falkmer UG, Yilmaz MK, Solheim TS, Balstad TR.

Crit Rev Oncol Hematol. 2019 Jul;139:96-107. doi: 10.1016/j.critrevonc.2019.04.014. Epub 2019 Apr 20.

PMID:
31150954
5.

Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer.

Poulsen LØ, Yilmaz MK, Ljungmann K, Jespersen N, Wille-Jørgensen P, Petersen LN, Falkmer UG.

Acta Oncol. 2018 Dec;57(12):1639-1645. doi: 10.1080/0284186X.2018.1497299. Epub 2018 Aug 31.

PMID:
30169998
6.

Is the accuracy of preoperative MRI stage in rectal adenocarcinoma influenced by tumour height?

Poulsen LØ, Yilmaz MK, Oddershede L, Bøgsted M, Holt G, Eld M, Ljungmann K, Falkmer UG.

Acta Oncol. 2018 Jun;57(6):728-734. doi: 10.1080/0284186X.2018.1433319. Epub 2018 Jan 31.

PMID:
29383974
7.

Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.

Christensen TD, Palshof JA, Larsen FO, Poulsen TS, Høgdall E, Pfeiffer P, Jensen BV, Yilmaz MK, Nielsen D.

Acta Oncol. 2018 Aug;57(8):1057-1062. doi: 10.1080/0284186X.2018.1433322. Epub 2018 Jan 30.

PMID:
29380640
8.

Extraction of a Foreign Body from the Breast Using Radio-guided Occult Lesion Localization (ROLL): Metallic Foreign Body in the Breast.

Dal F, Ökmen H, Yılmaz MK, Sarı S, Nazlı MA, Arslan E.

Eur J Breast Health. 2017 Jul 1;13(3):159-160. doi: 10.5152/ejbh.2017.3428. eCollection 2017 Jul.

9.

Risk factors for brain metastases in patients with metastatic colorectal cancer.

Christensen TD, Palshof JA, Larsen FO, Høgdall E, Poulsen TS, Pfeiffer P, Jensen BV, Yilmaz MK, Christensen IJ, Nielsen D.

Acta Oncol. 2017 May;56(5):639-645. doi: 10.1080/0284186X.2017.1290272. Epub 2017 Feb 22.

PMID:
28447565
10.

Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.

Larsen AC, Frøkjær JB, Fisker RV, Iyer V, Mortensen PB, Yilmaz MK, Møller B, Kristensen SR, Thorlacius-Ussing O.

Thromb Res. 2015 May;135(5):802-8. doi: 10.1016/j.thromres.2015.01.021. Epub 2015 Jan 29.

PMID:
25743885
11.

Venous thrombosis in pancreaticobiliary tract cancer: outcome and prognostic factors.

Larsen AC, Brøndum Frøkjaer J, Wishwanath Iyer V, Vincents Fisker R, Sall M, Yilmaz MK, Kuno Møller B, Kristensen SR, Thorlacius-Ussing O.

J Thromb Haemost. 2015 Apr;13(4):555-62. doi: 10.1111/jth.12843. Epub 2015 Feb 24.

12.

A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors.

Larsen AC, Holländer C, Duval L, Schønnemann K, Achiam M, Pfeiffer P, Yilmaz MK, Thorlacius-Ussing O, Bæksgaard L, Ladekarl M.

Ann Surg Oncol. 2015 May;22(5):1540-7. doi: 10.1245/s10434-014-4127-2. Epub 2014 Oct 28.

PMID:
25348777
13.

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Kjersem JB, Skovlund E, Ikdahl T, Guren T, Kersten C, Dalsgaard AM, Yilmaz MK, Fokstuen T, Tveit KM, Kure EH.

BMC Cancer. 2014 May 19;14:340. doi: 10.1186/1471-2407-14-340.

14.

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.

Schultz NA, Christensen IJ, Werner J, Giese N, Jensen BV, Larsen O, Bjerregaard JK, Pfeiffer P, Calatayud D, Nielsen SE, Yilmaz MK, Holländer NH, Wøjdemann M, Bojesen SE, Nielsen KR, Johansen JS.

PLoS One. 2013 Jun 26;8(6):e67059. doi: 10.1371/journal.pone.0067059. Print 2013.

15.

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, Sigurdsson F, Kure E, Ikdahl T, Skovlund E, Fokstuen T, Hansen F, Hofsli E, Birkemeyer E, Johnsson A, Starkhammar H, Yilmaz MK, Keldsen N, Erdal AB, Dajani O, Dahl O, Christoffersen T.

J Clin Oncol. 2012 May 20;30(15):1755-62. doi: 10.1200/JCO.2011.38.0915. Epub 2012 Apr 2.

PMID:
22473155
16.

Metastasis from pancreatic cancer located at the incision line of a mastectomy: a case report and review of literature.

Boysen AK, Haarh V, Soendergaard G, Yilmaz MK.

Gastrointest Cancer Res. 2011 Sep;4(5-6):194-6. No abstract available.

17.

Haemostatis activity in rectal cancer patients exposed to preoperative radiotherapy: a clinical prospective cohort study.

Stender MT, Larsen TB, Lundbye-Christensen S, Yilmaz MK, Thorlacius-Ussing O.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):276-82. doi: 10.1097/MBC.0b013e328329e4ae.

PMID:
19318923
18.

Half body irradiation of patients with multiple bone metastases: a phase II trial.

Berg RS, Yilmaz MK, Høyer M, Keldsen N, Nielsen OS, Ewertz M.

Acta Oncol. 2009;48(4):556-61. doi: 10.1080/02841860802488128.

PMID:
18979285
19.

[Preventive strategies against infections in autologous bone marrow transplantation].

Olesen G, Yilmaz MK, Palshof T, Møller JK, Peterslund NA.

Ugeskr Laeger. 1997 Mar 3;159(10):1438-42. Danish.

PMID:
9082631

Supplemental Content

Loading ...
Support Center